Education
About Us
Working with TipRanks
Follow Us
Kyle Malady Insider Profile
4 Followers
Kyle Malady, EVP and Group CEO-VZ Business at Verizon, holds 18.41K shares in Verizon (Ticker: VZ), holds 18.14K shares in Dexcom (Ticker: DXCM). Most recently, Kyle Malady Sold ― shares of Verizon on Feb 06, 2025 for an estimated value of 261.62K.
Kyle Malady Verizon (VZ)EVP and Group CEO-VZ Business
Verizon (VZ)
EVP and Group CEO-VZ Business
Ranked #78,602 out of 100,956 Corporate Insiders
Profitable Transactions
0 out of 7 Profitable Transactions
Average Return
-15.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kyle Malady holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kyle Malady
Kyle Malady's Trading History
Verizon
Feb 06, 2025
EVP and Group CEO-VZ Business
Informative Sell
261.62K
$848.19K
Dexcom
May 24, 2024
Director
Uninformative Buy
―
$1.41M
List of latest transactions for each holding click on a transaction to see Kyle Malady's performance on stock
You May Also Like
Kyle Malady insider profile FAQ
What is the percentage of profitable transactions made by Kyle Malady?
The percentage of profitable transactions made by Kyle Malady is 0%.
What is the average return per transaction made by Kyle Malady?
The average return per transaction made by Kyle Malady is -15.10%.
What stocks does Kyle Malady hold?
Kyle Malady holds: VZ, DXCM stocks.
What was Kyle Malady’s latest transaction?
Kyle Malady latest transaction was an Informative Sell of $261.62K.
What was Kyle Malady's most profitable transaction?
Kyle Malady’s most profitable transaction was an Informative Sell of VZ stock on February 20, 2024. The return on the trade was -11.90%.
What is Kyle Malady's role in Verizon?
Kyle Malady's role in Verizon is EVP and Group CEO-VZ Business.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.